Cort
Phoenix Rising Founder
- Messages
- 7,390
I recently received some documents from a Canadian companycalled KCLM wishing to push their kefir wares. You may recall that Dr. Logan noted that the probiotics in kefir are very different from those in yogurt and most probiotics preparations.
This article notes that even kefir preparations can differ greatly in the bacterial presentation. Interestingly it says the kefir grains do not need to be alive for them to be effective.
They noted interestingly enough that stomach upset was fairly normal at least at first but resolved over time.
They did an open label study with ME/CFS patients
The Second Study Comes Next
This article notes that even kefir preparations can differ greatly in the bacterial presentation. Interestingly it says the kefir grains do not need to be alive for them to be effective.
SKP is formulated to concentrate the bioactive components of kefir in an easily consumable form but does not contain live bacteria or yeasts due to a heat-inactivation process used, which allows for a more prolonged shelf life. SKP has shown remarkable improvements in clinical studies of individuals suffering from pain and fatigue.
They noted interestingly enough that stomach upset was fairly normal at least at first but resolved over time.
No serious adverse events were observed although some mild adverse events in terms of gastrointestinal events were noted; however, they were in a range of incidences of adverse effects that are very common in such studies. Probiotics such as the soy kefir powder of the present invention commonly show initially higher incidences of mild gastrointestinal upset that usually dissipate with more prolonged intakes.
They did an open label study with ME/CFS patients
. In the open label efficacy trial, two patients had to discontinue the treatment: one because of gastric pain after 3 days even though she said she had never felt so energetic from the time that she had the disease. She suggested that she wanted to try to take the product 1 or 2 days a week, as her improvements were so remarkable. The second patient had gastric discomfort and vomited at her first ingestion of the product. Increased satiety effects were also noted after the ingestion of the product. All other patients took the product for 4 weeks. For the statistical analysis, a two-tailed Wilcoxon test was used. The results of the questionnaire are assembled into 8 scales and the average score for each scale before and after the treatment were compared.
. Vitality was particularly greatly improved, as a significant increase in the sub-scale measure of vitality in the SF-32v2 questionnaire scores was demonstrated with a 12.8-point increase over baseline measures. A 5-point increase is considered to be clinically meaningful (Rowbotham, 2001).
Anecdotally, three of Dr. Garrels patients with chronic fatigue syndrome have now been taking SKP for more than 3 years now and they feel that they cannot endure without the product. For two of the patients, the SKP is very important for their pain relief whereas for the other patient the SKP is essential for vitality.
The Second Study Comes Next